INPLASY202170097

The time-varying cardiovascular benefits of glucagon like peptide-1 agonist (GLP-RA)therapy in patients with type 2 diabetes mellitus: A meta-analysis of multinational randomized trials

Keywords: diabetes mellitus; glucagon like peptide 1 receptor agonist; cardiovascular outcomes.

Download PDF - 202170097

Review Status: completed and published